Prosecution Insights
Last updated: April 19, 2026

PureTech LYT, Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18253756 ANTI-GALECTIN-9 ANTIBODIES AND THERAPEUTIC USES THEREOF LI, RUIXIANG 1674 Non-Final OA May 19, 2023
18250165 ANTI-GALECTIN-9 ANTIBODIES AND USES THEREOF IN THE TREATMENT OF OCULAR MELANOMA SUNSHINE, HANNAH LOUISE 1647 Non-Final OA Apr 21, 2023
17631378 COMBINED CANCER THERAPY OF ANTI-GALECTIN-9 ANTIBODIES AND CHEMOTHERAPEUTICS HALVORSON, MARK 1646 Final Rejection Jan 28, 2022

Managing PureTech LYT, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month